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Abstract This meta-analysis summarizes the accuracy of
magnetic resonance angiography (MRA) for diagnosing
residuals in coiled cerebral aneurysms by using the three-
fold Roy classification (residuals: none, neck, or sac). Four
databases were searched from 2000 to June 2013 for eli-
gible studies that compared MRA to digital subtraction
angiography (DSA) and reported 3 9 3 count data of
threefold Roy classification, or a reduced scheme of 2 9 2
count data. Bivariate and trivariate Bayesian random-
effects models were used for meta-analysis. Among 27
included studies (2,119 coiled aneurysms in 1,809 patients)
the average prevalence of DSA-confirmed sac residuals
was 18.2 % (range 0–43 %). The pooled sensitivity was
88.0 % (95 % CI 81.4-94.0) and specificity was 97.2 %
(94.6-99.0 %) for assessing sac residuals by MRA. In the
trivariate meta-analysis, a ‘‘sac residual’’ finding at MRA
had a high positive likelihood ratio of 28.2 (14.0–79.0). A
‘‘neck residual’’ finding had a moderate negative likelihood
ratio of 0.246 (0.111–0.426), and the MRA finding of ‘‘no
residual’’ had a good negative likelihood ratio of 0.044
(0.013–0.096). Subgroup analyses identified no significant
influence of covariates on diagnostic accuracy (P [ 0.05).
In conclusion, in coiled cerebral aneurysms MRA with
application of the threefold Roy classification is well suited
for detecting or excluding sac residuals that might require
retreatment.
Keywords Cerebral aneurysm  Coiling  Magnetic
resonance angiography  Meta-analysis  Diagnostic
accuracy
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Cerebral aneurysms can cause substantial morbidity and
mortality, especially if they rupture, leading to non-trau-
matic subarachnoid haemorrhage [1]. Symptomatic
patients are relatively young with an average age of about
50 years, and women are more often affected than men [2,
3]. In unruptured aneurysms the risk of further growth and
rupture is individually weighted against potential risks,
associated with coiling or clipping [4–8]. Ruptured cerebral
aneurysms are often treated by endovascular coiling or
neurosurgical clipping to prevent further bleeding [1, 9],
with long-term results of coiling being better than with
clipping [1, 9, 11]. However, coiling may contain the risk
of coil compaction, leading to a potential recurrence of the
aneurysm [1, 12]. This occurs in about 20–30 % of cases,
half of which are retreated [1, 13]. Coiled aneurysms are
therefore followed up routinely by angiography: In case of
recanalization of the aneurysm sac, endovascular retreat-
ment is often necessary [14]. In contrast, a pure neck
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residual is generally not retreated. The threefold Roy
classification considers this clinically relevant differentia-
tion between neck and sac residual (class 1 = no residual;
class 2 = pure neck residual; class 3 = sac residual) [15,
16].
Follow-up of coiled cerebral aneurysms has been tradi-
tionally performed by digital subtraction angiography
(DSA), the diagnostic reference standard [1]. Magnetic
resonance angiography (MRA) is a noninvasive alternative
that can be performed on an outpatient basis, without
ionizing radiation, and without catheter-related complica-
tions [1, 17]. For this purpose the diagnostic accuracy of
MRA must be adequate, which has been investigated by
several studies. Most initial studies have performed the
‘‘any residual’’ assessment (Roy class 1 versus classes
2 ? 3) that adds neck and sac residuals, although having
different clinical consequences. In 2007 and 2008 two
meta-analyses summarized those studies [18, 19]. Since
then, several new studies were published reporting 3 9 3
count data of the Roy classification. Many added a ‘‘sac
residual’’ assessment (Roy classes 1 ? 2 versus class 3). In
both standard assessments the 3 9 3 count data are
reduced to bivariate 2 9 2 count data, causing some loss of
information. In particular, this prevents assessing likeli-
hood ratios and predictive values of MRA for the three Roy
classes. This requires a trivariate analysis of the 3 9 3
count data, not performed so far.
The purpose of the present meta-analysis was to deter-
mine the diagnostic accuracy and predictive value of MRA
for assessing flow residuals in coiled cerebral aneurysms
compared to DSA, by applying bivariate and trivariate
statistical approaches, and by including primary studies
that have not been meta-analyzed before.
Methods
This work applied the Preferred Reporting Items for Sys-
tematic reviews and Meta-Analyses (PRISMA guideline)
without prepublication of the review protocol [20, 21].
Data Sources and Searches
The PubMed, Scopus, Biosis and ISI databases were
searched for ‘‘coiled cerebral aneurysm’’, ‘‘MRA’’,
‘‘DSA’’, and related terms from January 2000 to June 2013
without language restriction (Online Table e1). Reference
lists of retrieved articles were also searched.
Study selection
Two observers independently selected eligible studies with
disagreement solved in consensus. The inclusion criteria
were: (a) the patients harbored one or more cerebral
aneurysm(s) treated with detachable coils; (b) the study
included at least 10 coiled aneurysms and was not limited
to specific aneurysm sizes or locations; (c) MRA, the index
test, was performed with one or more of these sequences:
time-of-flight (TOF-MRA), contrast-enhanced TOF (ce-
TOF-MRA), and/or contrast-enhanced T1-weighted (CE-
MRA); (d) DSA was the reference standard; (e) 3 9 3
count data of the Roy classification, or 2 9 2 count data of
the ‘‘any residual’’ or ‘‘sac residual’’ assessment could be
reconstructed. A study was excluded if it did not meet all of
these inclusion criteria. If a research group reported
growing experience in successive publications, then only
the most recent publication was included to avoid duplicate
counting of findings.
Data extraction
Data from included studies were independently extracted
by two observers using electronic forms, with disagreement
solved in consensus. Extracted study characteristics com-
prised details about study design, patients, MRA, and DSA.
Count data were extracted on a per-aneurysm basis. Some
additional data were obtained from the study authors via
e-mail.
Study quality and risk of bias
On the study level, the methodological quality and sources
of bias were assessed by the 14 quality items of the
QUADAS tool [22]. Item 4 was scored positive, if the
delay between MRA and DSA was B10 days in all
patients. For each study a quality score was calculated by
assigning 1 point for each QUADAS item if fulfilled, 0.5
points if unclear, and 0 points if not fulfilled. A score C11
points was considered as high study quality. On the out-
come level, publication bias was assessed by a funnel plot
and bivariate meta-regression of the LOR (Logarithm of
the diagnostic Odds Ratio) versus the effective sample size
parameter, as previously described [23, 24].
Contingency tables
If any study had investigated more than one MRA
sequence, the according raw 2 9 2 or 3 9 3 count data
were averaged to obtain one contingency table per study.
Such averaging was not performed for subgroup analyses
that investigated differences among the MRA sequences.
Bivariate Meta-analyses
For the ‘‘any residual’’ and ‘‘sac residual’’ assessments, the
studies’ sensitivities/specificities as well as Cochran’s
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Q-test and I-squared statistics of between-study heteroge-
neity were calculated by the freeware program Meta-DiSc
[25]. Pooled summary estimates of sensitivity and speci-
ficity were obtained from a bivariate random-effects meta-
analysis [26, 28]. This kind of meta-analysis models
between-study heterogeneity with normally distributed
bivariate random effects that account for a possible corre-
lation between sensitivity and specificity [26, 29–31]. The
summary estimates were also transformed to positive and
negative likelihood ratios that can be used for calculating
conditional probabilities (Table e-2) [24, 32–34]. Positive
likelihood ratios [10 were considered suitable for con-
firming aneurysm residuals, and negative likelihood ratios
\0.1 suitable for excluding them.
Trivariate meta-analysis
However, the bivariate standard assessments do not fully
consider the threefold Roy classification, since they add
neck residuals to either the ‘‘no residual’’ or ‘‘sac resid-
ual’’ class. Therefore, an additional trivariate random-
effects meta-analysis was performed with 3 9 3 count
data of the Roy classification [26, 31, 35]. In this
approach three likelihood ratios were derived. They
indicate the relative likelihood of having a DSA-con-
firmed sac residual, if MRA indicates ‘‘no residual’’ (first
negative likelihood ratio, LRN1), or if MRA indicates a
‘‘neck residual’’ (second negative likelihood ratio, LRN2),
or if MRA indicates a ‘‘sac residual’’ (positive likelihood
ratio, LRP). These three likelihood ratios were used for
generating a trivariate graph of conditional probabilities
(Table e-3).
Subgroup analyses
Potential sources of heterogeneity were assessed by sub-
group analyses of the ‘‘sac residual’’ assessment, with the
study characteristics as categorical covariates in bivariate
random-effects meta-regressions [36]. In each subgroup the
overall diagnostic accuracy was indicated by the LOR, with
LOR = logit(sensitivity) ? logit(specificity) [31, 37]. A
significant difference between the subgroups was assessed,
if the 95 % credible interval (95 % CI) of the LOR-dif-
ference excluded zero (P \ 0.05).
Bayesian meta-analysis program
Meta-analyses were performed with the Bayesian PROC
MCMC from SAS 9.3 (SAS Institute Inc., Cary, NC, USA)
that obtains its results from numerical simulation rather
than analytically or by iterative approximation [26–28].
Referring to the Bayesian reporting guideline ‘‘ROBUST’’
[38], the program has the following characteristics: A
multivariate Normal prior with large variances was used
for the logit-transformed pooled sensitivity and specificity.
In the relevant logit-range of -10 to 10, this prior is nearly
uniform (flat), and thus uninformative. This logit-range
corresponds to a sufficiently broad range of
0.005–99.995 % for sensitivity and specificity on the
probability scale. For the random effects a bivariate Nor-
mal prior was used [26–31]. A sensitivity analysis was
performed by using different initials for the priors [26]. The
program output included the mean (measures the central
tendency) and 95 % credible interval (95 % CI measures
the variability) of the model estimates [26]. The latter
corresponds to a ‘‘95 % confidence interval’’ in classical
statistics. The trivariate meta-analysis is an extension of the
bivariate meta-analysis [26, 31, 35]. The meta-analytic
programs always converged to unique posterior
distributions.
Results
Literature search and selection
Among 2,581 retrieved sources, 2,536 were excluded by
reading titles and abstracts, and 18 by evaluating the full
text (Fig. 1). The remaining 27 studies were included.
While 10 studies [e1-e10] had been part of two previous
meta-analyses [17–19], the remaining studies had not been
meta-analyzed before [e11-e27].
Literature Search (from January 2000 to June 2013):
Electronic databases (PubMed, Scopus, BIOSIS, and ISI)
and reference lists of retrieved articles 
Sources possibly fulfilling inclusion criteria (n = 2581) 
Excluded by reading titles and abstracts (n = 2536) 
Full text retrieved and assessed (n = 45) 
Excluded after evaluation of the full text (n = 18) 
 7 studies: Repeated reporting in updated studies
 6 studies: Count data could not be reconstructed
 3 studies: Not about diagnostic accuracy 
 1 study  : Limited to ACoA aneurysms 
 1 study  : Limited to residual / recurrent aneurysms 
Included in the meta-analysis (n = 27) 
Fig. 1 Study flow chart
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Descriptive statistics
Nineteen studies were prospective, six retrospective, and in
two studies the design was unclear. One multicenter study
provided data from four centers [e23]. On average, about
69 % of patients were female (range 36–92 %), the mean/
median patient age was 51 years (range 8–90 years), and
about 85 % of patients had received coiling of a ruptured
aneurysm (range 5–100 %). Most patients had a single
coiled aneurysm (mean 1.2 coiled aneurysms per patient).
The 27 studies had included 2,119 coiled aneurysms of
1,809 patients. About 80 % of the aneurysms were located
in the anterior and 20 % in the posterior circulation [e1-
e27]. Twelve studies reported the aneurysm size before
coiling in millimeter categories [e1, e2, e4, e5, e7-e11,
e18, e24, e27]. About 29 % of them were small (up to
4 mm), 46 % medium-sized (5–10 mm), and 25 % large
(C11 mm). Six studies reported 2 9 2 count data exclu-
sively of the ‘‘any residual’’ assessment (Roy class 1 versus
classes 2 ? 3) in 566 aneurysms. The other 21 studies
provided 3 9 3 count data in 1,553 aneurysms. Among
these 21 studies, DSA showed on average 53.8 % complete
occlusions (range 14–91 %), 28.0 % neck residuals (range
4–68 %), and sac residuals 18.2 % (range 0–43 %). In
most cases, follow-up was performed 3–24 months after
coiling. Twelve studies compared two or more different
MRA sequences to DSA. In total, 1,365 coiled aneurysms
were studied by 1,216 TOF-MRA, 232 aneurysms by 206
ceTOF-MRA, 660 aneurysms by 569 CE-MRA, and 503
aneurysms by 460 MRA with mixed sequences. About
72 % of MRA were performed at 1.5 Tesla and 28 % at 3.0
Tesla. In most studies the MRA readers were blinded to the
DSA results, and vice versa (eFig. 1). Further descriptive
data are provided in Table e-4 (study characteristics) and
Table e-5 (reasons for exclusion of patients/aneurysms
from the primary studies).
Study quality, publication bias, and heterogeneity
The study quality was generally high (eFig. 1). The funnel
plot and regression test indicated no significant publication
bias (P = 0.44). The between-study heterogeneity was low
to moderate (P \ 0.05; I2 29–72 %).
Reproducibility of MRA
In 10 studies the interobserver reproducibility of MRA was
reported by j—statistics [e10, e16, e18-e20, e22-e24,
e26, e27]. The median j-statistics was 0.60 (range
0.56–0.80) for the bivariate ‘‘any residual’’ assessment,
0.74 (0.63–0.77) for the bivariate ‘‘sac residual’’ assess-
ment, and 0.64 (0.49–0.93) for the trivariate assessment,
indicating moderate to good inter-observer agreement. Five
of these studies compared TOF-MRA versus CE-MRA
and/or compared MRA at 1.5 versus 3.0 Tesla [e20, e22,
e24, e26, e27]. Among these studies, the according inter-
observer reproducibility showed no consistent trend in
favor of a certain MRA technique.
Count data of individual studies
For the individual studies, 2 9 2 count data of the ‘‘any
residual’’ and ‘‘sac residual’’ assessment and corresponding
estimates of sensitivity and specificity are given in Table
e-6. Table e-7 provides trivariate 3 9 3 count data of the
Roy classification.
Bivariate meta-analysis of sensitivity and specificity
Diagnosing ‘‘any residual’’ (neck or sac) by MRA showed a
pooled sensitivity of 89.0 % (95 % CI, 85.1-92.6 %) and
specificity of 89.0 % (82.6-94.0 %) (Table 1). Diagnosing
a ‘‘sac residual’’ had a pooled sensitivity of 88.0 % (95 %
CI, 81.4-94.0 %) and specificity of 97.2 % (94.6-99.0 %).
The positive likelihood ratio was high for diagnosing a ‘‘sac
residual’’ (mean 33.6) and moderate for diagnosing ‘‘any
residual’’ (mean 8.4). Both standard assessments showed
moderate negative likelihood ratios (mean 0.12).
Trivariate meta-analysis and conditional probabilities
The Roy class of aneurysm residuals was correctly assessed
by MRA in 86.8 % (95 % CI, 80.5–91.8 %) of cases, whereas
underestimation occurred in 5.6 % (3.5–8.0 %) and overes-
timation in 7.6 % (3.7–12.9 %) of cases. It was rare that MRA
deviated from DSA by two classes, i.e. that MRA indicated
‘‘no residual’’ in a DSA-confirmed sac residual (2.7 %) or a
‘‘sac residual’’ in a DSA-confirmed occluded aneurysm
Table 1 Bivariate meta-analytic summary estimates
Meta-analytic parameters Aneurysm assessment
Any residuala Sac residualb
Study centers 30 23
Coiled aneurysms 2,119 1,553
Sensitivity (95 % CI), % 89.0 (85.1–92.6) 88.0 (81.4–94.0)
Specificity (95 % CI), % 89.0 (82.6–94.0) 97.2 (94.6–99.0)
LOR (95 % CI) 4.22 (3.57–4.95) 5.65 (4.56–7.00)
LRP (95 % CI) 8.35 (5.10–14.87) 33.6 (15.7–89.5)
LRN (95 % CI) 0.12 (0.08–0.17) 0.12 (0.06–-0.19)
LOR, logarithm of the diagnostic odds ratio
LRP positive likelihood ratio
LRN negative likelihood ratio
a No residual (class 1) versus neck or sac residual (classes 2 or 3)
b No or neck residual (classes 1 or 2) versus sac residual (class 3)
658 J Neurol (2014) 261:655–662
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(1.7 %). The positive likelihood ratio (LRP = 28.2) of ‘‘sac
residual at MRA’’ was above 10, indicating the suitability of
MRA for detecting true sac residuals. The negative likelihood
ratio of ‘‘no residual at MRA’’ (LRN1 = 0.044) was below
0.1, indicating this finding’s suitability for excluding sac
residuals. The negative likelihood ratio of ‘‘neck residual at
MRA’’ (LRN2 = 0.246) was above 0.1, indicating limited
value of that intermediate finding for excluding sac residuals.
Corresponding trivariate conditional probabilities are pre-
sented in Fig. 2. At a pretest probability of 18.2 % for sac
residuals (the average prevalence among the studies), a ‘‘neck
residual’’ finding at MRA has a negative predictive value
(NPV2) of about 94.7 %, and is therefore still a useful finding
(Table 2). At that pretest probability, a ‘‘no residual at MRA’’
finding excludes a sac residual in about 99.0 % of cases, and a
‘‘sac residual at MRA’’ finding is true in about 87.9 % of
cases.
Meta-analytic subgroup analyses
The subgroup analyses showed no significant differences in
diagnostic accuracy (P [ 0.05). This referred to MRA
sequence (TOF-MRA versus CE-MRA), field strength (1.5
versus 3.0 Tesla), number of MRA readers (1 versus 2–3),
and several other covariates (Table e-8). The 19 included
prospective studies showed results similar to those reported
in Tables 1 and 2.
Discussion
This meta-analysis confirms that noninvasive MRA is
generally well suited for assessing flow residuals in coiled
cerebral aneurysms. This is relevant both to imaging spe-
cialists and referring clinicians, since both partners decide
about using DSA or MRA for the follow-up of the coiled
aneurysms, and about how to proceed with the obtained
imaging results. MRA is attractive, since it can be per-
formed on an outpatient basis, is fast, obviates catheter-
related complications, and requires less personnel than
DSA. This is the first meta-analysis that fully considers the
threefold Roy classification of aneurysm residuals (no,
neck, or sac residual) [15, 16]. It shows that the according
threefold MRA results have different likelihoods for
detecting/excluding a true sac residual (that might require
retreatment). This should be considered in MRA-based
decision making.
The reported per-aneurysm results approximately rep-
resent per-patient results, since most patients had a single
coiled aneurysm. DSA showed on average 53.8 % com-
plete occlusions (Roy class 1), 28.0 % neck residuals (class
2), and 18.2 % sac residuals (class 3). MRA correctly
assessed about 86.8 % of cases, and over-/underestimated
8.8 % of cases by one Roy class. Over-/underestimation by
two classes was more rare (4.4 %).
Differentiating neck and sac residuals is clinically rel-
evant, since about 50 % of sac residuals are retreated,
whereas neck residuals are generally not retreated [1, 10].
Neck residuals and no residuals therefore generally have
the same consequence of watchful waiting. Their MRA-
based differentiation is nevertheless useful, since ‘‘no
residual at MRA’’ rules out a sac residual with higher
diagnostic confidence than ‘‘neck residual at MRA’’.
The simple bivariate ‘‘any residual’’ assessment (no
residual versus any neck/sac residual) might indicate just
moderate diagnostic accuracy of MRA for aneurysm residu-
als. However, in that assessment the sac and neck residuals are
summed to one group, although having different therapeutic
implications. The according statistical results are therefore
clinically less meaningful than the bivariate ‘‘sac residual’’
assessment or the more detailed trivariate assessment.
The refined bivariate ‘‘sac residual’’ assessment (no or
neck residual versus sac residual) shows a high specificity,
i.e. the number of false-positive sac residual findings at
MRA is small. Accordingly, the positive predictive value is
nearly similar to the trivariate assessment. However, the
Fig. 2 Trivariate conditional probabilities. This graph shows post-
test probabilities for having or not having an aneurysmal sac residual,
depending on the pre-test probability for sac residuals, and depending
on the test result of MRA. This trivariate MRA result is categorized as
Roy class 1 (no residual), class 2 (neck residual), or class 3 (sac
residual). The central black curves are means, and the surrounding
wings represent the according 95 % CI. An example is given for the
studies’ average prevalence of sac residuals that was 18.2 % (vertical
line, indicated by ‘‘pre-test probability = 18.2 %’’). If MRA indicates
a ‘‘class 1 = no residual’’ finding, then the average post-test
probability for truly having no sac residual is 99.0 %, which is the
studies’ mean negative predictive value 1 (NPV1). If MRA indicates a
‘‘class 2 = neck residual’’ finding, then the average post-test prob-
ability for truly having no sac residual is 94.7 %, which is the studies’
mean negative predictive value 2 (NPV2). If MRA indicates a ‘‘class
3 = sac residual’’ finding, then the average post-test probability for
truly having a sac residual is 87.9 %, which is the studies’ mean
positive predictive value (PPV)
J Neurol (2014) 261:655–662 659
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bivariate ‘‘sac residual’’ assessment does not differentiate
the predictive value of the Roy classes 1 and 2.
The trivariate meta-analytic assessment is considered to
be the best approach, since it fully accounts for the 393
data of the Roy classification. In the trivariate meta-anal-
ysis, the finding of ‘‘no residual at MRA’’ showed a good
negative likelihood ratio (mean 0.044) for ruling out a true
sac residual. Among the studies the mean prevalence of sac
residuals was 18.2 %, and at this prevalence an MRA
finding of ‘‘no residual’’ truly excludes a sac residual in
99.0 % of cases, obviating the need for additional DSA. In
aneurysms with adequate occlusion 6 months after coiling
(those \10 mm and not located on the basilar tip), pro-
longed imaging follow-up seems unnecessary, since late
reopening with need of retreatment is very rare [39].
The intermediate finding of ‘‘neck residual at MRA’’
had only a moderate negative likelihood ratio (mean 0.246)
for ruling out a true sac residual. However, the according
predictive value depends on the pretest probability, as
visualized in the graph of conditional probabilities (Fig. 2).
At a pretest probability of 18.2 % for sac residuals, this
MRA finding is still useful, since the associated negative
predictive value is high (mean 94.7 %). Additional DSA
may be considered optional, since it shows a sac residual in
only about 5.3 % of cases, and therefore further follow-up
is a suitable diagnostic alternative.
The finding of ‘‘sac residual at MRA’’ had a high
positive likelihood ratio (mean 28.2), and is therefore well
suited for detecting a true sac residual. DSA may then be
subsequently performed to exclude some false-positives,
and to evaluate retreatment in the approximately 87.9 % of
cases with true sac residuals [1, 10]. However, such DSA is
optional on an individual basis, since MRA may generally
be used for deciding about retreatment versus further fol-
low-up [40]. Most studies of this meta-analysis were pro-
spective with consecutive patient enrollment and blinding
of MRA versus DSA assessments, contributing to class I
evidence that MRA is useful for diagnosing flow residuals
in coiled cerebral aneurysms.
Some primary studies had found differences in diagnostic
accuracy among different MRA methodologies. However,
on the meta-analytic level the according subgroup analyses
showed no consistent significant differences. For example,
MRAs with 1.5 Tesla magnets generally performed similar
to 3.0 Tesla. Additionally, double-reading of MRA is not
mandatory, since single-reading has similar diagnostic
accuracy, if performed by an appropriately trained radiolo-
gist. The accuracy of TOF-MRA was not significantly dif-
ferent from contrast-enhanced MRA. While the former
requires more acquisition time than the latter, it saves on the
costs of contrast medium and avoids the small potential risks
of contrast medium in patients with renal failure.
Table 2 Trivariate meta-analytic summary estimates
DSA Likelihood ratios Predictive values
No residual Neck residual Sac residual
(Roy class 1) (Roy class 2) (Roy class 3) For sac residuals For sac residualsa
MRA
No residual 89.0 % 12.9 % 2.7 % LRN1 = 0.044 NPV1 = 99.0 %
(Roy class 1) (80.6–95.1 %) (6.9–19.8 %) (0.8–5.6 %) (0.013–0.096) (97.9–99.7 %)
MRA
Neck residual 9.3 % 81.0 % 8.6 % LRN2 = 0.246 NPV2 = 94.7 %
(Roy class 2) (4.0–16.6 %) (71.4–89.4 %) (3.7-14.3 %) (0.111–0.426) (91.4–97.6 %)
MRA
Sac residual 1.7 % 6.1 % 88.7 % LRP = 28.2 PPV = 87.9 %
(Roy class 3) (0.5–3.5 %) (2.0–11.3 %) (82.7–94.2 %) (14.0–79.0) (75.6–94.5 %)
Sum 100 % 100 % 100 %
a At an average pretest probability of 18.8 % for the prevalence of sac residuals
LRN1 negative likelihood ratio 1 (for sac residual at DSA, if MRA indicates no residual), LRN2 negative likelihood ratio 2 (for sac residual at
DSA, if MRA indicates a neck residual), LRP positive likelihood ratio (for sac residual at DSA, if MRA indicates a sac residual), NPV1 negative
predictive value 1 (for excluding a true sac residual, if MRA indicates no residual), NPV2 negative predictive value 2 (for excluding a true sac
residual, if MRA indicates a neck residual), PPV positive predictive value (for detecting a true sac residual, if MRA indicates a sac residual)
The 3 9 3 count data from 21 studies (1,553 coiled aneurysms) were summarized by a random-effects meta-analysis. The meta-analytic results
are expressed as probabilities (with 95 % CI in brackets). With DSA as reference standard, MRA correctly assessed the residual status in 86.7 %
(95 % CI: 80.5–91.8) of coiled aneurysms (bold, diagonal), underestimated 5.6 % (3.5–8.0 %) of residuals (italic, upper right triangle), and
overestimated residuals in 7.6 % (3.7-12.9 %) of cases (lower left triangle). Both right columns present likelihood ratios (LR) and predictive
values (PV) for sac residuals. The predictive values were estimated for a pretest probability of 18.2 %, which was the studies’ average prevalence
of sac residuals
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Two previous meta-analyses summarized findings in
about 800–880 coiled aneurysms from studies published
between 1997 and 2006 [18, 19]. Our meta-analysis applied
a generalized linear mixed model that is considered more
appropriate than the previously applied general model [18,
19, 26, 31]. The primary studies of both previous meta-
analyses had provided count data only for the 292 ‘‘any
residual’’ assessment. Since then several studies have been
published providing 3 9 3 count data of the Roy classifi-
cation. Therefore, the current meta-analysis includes 17
novel studies, increases the number of meta-analysed
aneurysms to more than 2,100, and can provide the ‘‘sac
residual’’ and trivariate assessments.
This meta-analysis has some limitations. MRA after
stent-assisted coiling was not meta-analysed, since
according publications are currently too few [41–44]. This
meta-analysis did not stratify the diagnostic accuracy of
MRA for aneurysm size because of having no data.
According to two primary studies, the sensitivity and
specificity of MRA for diagnosing sac residuals after
coiling is lower in small aneurysms than in large aneu-
rysms [e11, e25]. Consequently, the diagnostic accuracy of
MRA in large aneurysms would be higher than indicated
by our pooled estimates, which also summarize small
aneurysms. This is favorable, since coiled large aneurysms
require retreatment more frequently than small aneurysms
[14].
In conclusion, non-invasive MRA with application of
the threefold Roy classification is well suited for assessing
flow residuals in coiled cerebral aneurysms. A ‘‘sac resid-
ual’’ finding at MRA should be confirmed by catheter
angiography to exclude false-positives and to possibly
retreat the true-positives. A ‘‘neck residual’’ finding at
MRA should be followed up further. An MRA finding of
‘‘no residual’’ generally requires no confirmation by DSA.
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